![Mette Husbyn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mette Husbyn
Hoofd Techniek/Wetenschap/O&O bij
LYTIX BIOPHARMA ASA
Profiel
Mette Husbyn currently works at Lytix Biopharma AS, as Chief Technical Officer from 2025.
Dr. Husbyn also formerly worked at Lytix Biopharma AS, as Head-CMC from 2012 to 2017 and Nykode Therapeutics ASA, as Chief Technical Officer & Head-CMC from 2017 to 2025.
Dr. Husbyn received her doctorate degree in 2003 from the University of Oslo.
Actieve functies van Mette Husbyn
| Bedrijven | Functie | Begin |
|---|---|---|
| LYTIX BIOPHARMA ASA | Hoofd Techniek/Wetenschap/O&O | 01-02-2025 |
Eerdere bekende functies van Mette Husbyn
| Bedrijven | Functie | Einde |
|---|---|---|
| NYKODE THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-01-2025 |
| LYTIX BIOPHARMA ASA | Corporate Officer/Principal | 01-01-2017 |
Opleiding van Mette Husbyn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
